期刊文献+

shRNA抑制COX-2基因表达对肝癌细胞HepG_2生长的影响 被引量:1

Effects of COX-2 gene expression inhibited by shRNA on growth of hepatocellular carcinoma HepG_2 cells
暂未订购
导出
摘要 目的:应用RNA干扰技术抑制COX-2基因,观察其对肝癌细胞HepG2生长的影响.方法:构建靶向抑制COX-2基因表达的短发夹双链RNA(shRNA)真核表达载pshRNA-COX-2,转染肝癌细胞HepG2,用RT-PCR和Western Blot分别从mRNA和蛋白水平检测其对COX-2的抑制效应,MTT法检测对HepG2细胞生长的影响.结果:与未转染组相比,pshR-NA-COX-2重组表达质粒抑制了HepG2细胞COX-2mRNA及蛋白表达,抑制率分别为69.9%和50.3%;并可抑制HepG2细胞生长,72h后有统计学差异(P<0.05).结论:pshRNA-COX-2重组表达载体能显著抑制肝癌细胞COX-2基因表达,从而抑制肿瘤细胞增殖. AIM: To investigate the effects of inhibition of cyclooxygenase-2 (COX-2) with RNA interference (RNAi) on the growth of hepatocellular carcinoma HepG2 cells. METHODS: The eukaryotic expression plasmid of short hairpin RNA (shRNA) targeting COX-2 gene (pshRNA-COX-2) was constructed and transfected into hepatocellular carcinoma HepG2 cells; the expressions of COX-2 mRNA and protein were detected with reverse transcriptional polymerase chain reaction (RT-PCR) and Western Blot assay, respectively. The growth of HepG2 cells was detected by MTY. RESULTS: Compared with untransfected group, recombinant expression vector pshRNA-COX-2 resulted in the reduction of COX-2 mRNA and protein by 69.9% and 50.3% respectively, and the growth of HepG2 cells was significantly inhibited after 72 h ( P 〈 0.05 ) . CONCLUSION : Recombinant expression vector pshRNA-COX-2 can significantly inhibit the expression of COX-2 gene , and suppress the growth of tumor cells.
出处 《第四军医大学学报》 北大核心 2007年第14期1272-1274,共3页 Journal of the Fourth Military Medical University
基金 重庆市自然科学基金项目(2006BB5271)
关键词 RNA干扰 重组表达载体 环氧化酶-2 肝肿瘤 RNA interference recombinant expression vcectors cyclooxygenase-2 liver neoplasms
  • 相关文献

参考文献8

  • 1Singh B,Berry JA,Shoher A,et al.COX-2 overexpression increases motility and invasion of breast cancer cells[J].Int J Oncol,2005,26(5):1393-1399.
  • 2郭贵龙,姚榛祥,吴坚.环氧化酶-2基因在人乳腺癌中的表达及临床意义[J].中华医学杂志,2003,83(19):1661-1664. 被引量:38
  • 3Lu S,Yu G,Zhu Y,et al.Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation,apoptosis and differentiation,and causes partial transformation[J].Int J Cancer,2005,116(6):847-852.
  • 4Yuan A,Yu CJ,Shun CT,et al.Total cyclooxygenase-2 mRNA levels tumor angiogenesis and prognosis in non-small cell lung cancer patients[J].Int J Cancer,2005,115(4):545-555.
  • 5Wang W,Bergh A,Damber JE.Cycloogenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer[J].Clin Cancer Res,2005,11(9):3250-3256.
  • 6Iwamoto A,Ikeguchi M,Matsumoto et al.Tumor cyclooxygenase-2 gene suppress local immune responses in patients with hepatocellular carcinoma[J].Tumroi,2006,92(2):130-133.
  • 7张鹏辉,涂植光,杨明清,黄文方,邹琳,周亚莉.RNA干扰技术靶向hTERT基因治疗肝癌的实验研究[J].癌症,2004,23(6):619-625. 被引量:30
  • 8闫歌 ,蒲丹 ,唐霓 ,高小玲 ,宋文鑫 ,卢年芳 ,吴刚 ,Tong-Chuan He ,黄爱龙 .RNA干扰技术对肝癌细胞内源survivin基因表达的影响[J].生物化学与生物物理进展,2004,31(9):829-833. 被引量:16

二级参考文献29

  • 1Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma. Nat Med, 1997, 3(8): 917 -921
  • 2Grossman D, Kim P, Schechner J S, et al. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA,2001, 98 (2): 635 -640
  • 3Mesri M, Wall N R, Li J, et al. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest, 2001, 108 (7): 981 -990
  • 4Tuschl T. Expanding small RNA interference. Nat Biotechnol,2002, 20 (5): 446 - 448
  • 5Olie R A, Simoes-Wust P, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res, 2000, 60(11): 2805-2809
  • 6McManus M T, Sharp P A. Gene silencing in mammals by small interfering RNAs. Nature Rev Genet, 2002, 3 (10): 737 -747
  • 7Aoki Y, Cioca D P, Oidaira H, et al. RNA interference may be more potent than antisense RNA in human cancer cell lines. Clin Exp Pharmacol Physiol, 2003, 30 ( 1 - 2 ): 96 - 102
  • 8Song E, Lee S K, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 2003, 9 (3):347 - 351
  • 9Cioca D P, Aoki Y, Kiyosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther, 2003, 10 (2): 125 -133
  • 10Nagao K, Tomimatsu M, Endo H, et al. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma [J]. J Gastroenterol, 1999, 34(1 ): 83 -87.

共引文献78

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部